United States Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies

1
United States Diabetes Market
United States Diabetes Market
2
Report Description and Highlights
Diabetes is rising at an alarming rate in the
United States. Diabetes referred to as diabetes
mellitus, is a group of metabolic diseases in
which a person suffers from high blood glucose.
If diabetes not appropriately monitored, then it
can be fatal and cause serious health
complications such as kidney diseases, heart
diseases, amputation, stroke and blindness.
Between the year 2000 and 2019, the number of
people living with diabetes tripled and the
number of new cases annually (incidence) doubled
in the United States. The United States
represents the third-largest diabetes patient
pool owing to the increasing geriatric population
and rising obesity levels in 2018. United States
Diabetes Market is expected to reach USD 23.29
Billion by the year 2025.
United States Diabetes Market
3
United States Diabetes Market
The use of continuous glucose monitoring systems
and continuous subcutaneous insulin infusion has
gained full acceptance in diabetes care. These
devices have demonstrated to be clinically
valuable, reducing risks of hypoglycemia and
improving glycemic control in ambulatory patients
with type 1 diabetes type 2 diabetes. Because
of this tremendous improvement in the number of
patients, especially that requiring insulin
therapy, the cost of healthcare-related to
diabetes and its complications is ever
increasing. The market of Insulin Pen, Insulin
Pump, Continuous Glucose Monitoring (CGM) Device
and Self Monitoring Blood Glucose Device are
growing due to the rise in numbers of diabetic
patients in the United States.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lunited-states-diabetes-market-p.php
United States Diabetes Market
4
United States Diabetes Market
The increasing diabetes prevalence has led the
U.S. Government to launch diabetes to raise
awareness and prevention programs about its
symptoms and encourage healthier lifestyle
behavior amongst the citizens. In 2019, Abbott
Laboratories planned to ramp up manufacturing
capacity for its lower-cost continuous glucose
monitor (CGM) device in the next few years,
targeting to reach millions of more patients
worldwide, According to Reuters. In March 2018,
Sanofi-aventis U.S. LLC received approval from
the U.S. Food and Drug Administration for Toujeo
Max SoloStar.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlunited-states-diabetes-market-p.php
United States Diabetes Market
5
United States Diabetes Market
Renub Research report titled United States
Diabetes Market Forecast, By Continuous Glucose
Monitoring (CGM Market by Components, Glucose
Sensor, Transmitter, CGM User, Reimbursement),
Self Monitoring Blood Glucose Device Analysis
(SMBG Market by, Test Strips, Lancet, Meter,
Blood Glucose Device Users Reimbursement)
Insulin Pen Analysis (User, Types Disposable,
Reusable and Smart Insulin Pen, Insulin Pen
Needle Market, Reimbursement Policies), Insulin
Pump Market, (Differentiation Points of Insulin
Pump Products, Training Model for Patients HCP,
USA (By States) Diabetes Supplies, Insulin Pump
Pump Supplies Reimbursement Policies by
State-Sponsored Health Program) Companies (B.
Braun Melsungen AG, Eli Lilly and Company,
Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford
Ltd, Ypsomed AG, Medtronic, Insulet Corporation,
LifeScan Inc., Abbott Laboratories)" provides a
complete analysis of United States Insulin
Delivery Devices Market.
United States Diabetes Market
6
United States Diabetes Market

• Segments Market based on Devices
• 1.    Continuous Glucose Monitoring (CGM) 2.  
   Self Monitoring Blood Glucose (SMBG)3.  
   Insulin Pen 4.    Insulin Pump
• United States Diabetes Sub-Segment Analysis 
• Continuous Glucose Monitoring (CGM)
• 1.    Glucose Sensor Market Forecast 2.    CGM
  Transmitter Market Forecast3.    CGM
  User 4.    CGM Reimbursement
• 2. SMBG
• 1.    Test Strips Market and Forecast 2.  
   Lancet Market and Forecast3.    Meter Market
  and Forecast 4.    Blood Glucose (SMBG)
  Users5.    Blood Glucose Devices Reimbursement

United States Diabetes Market
7
United States Diabetes Market
3. Insulin Pen Market 1.    Disposable Insulin
Pen2.    Reusable Insulin Pen3.    Smart
Insulin Pen4.    Insulin Pen Needle Market5.  
 Reimbursement Policies 4. Insulin Pump
Market 1.    Insulin Pump Market2.    USA (By
States) Diabetes Supplies3.    Reimbursement
Policies by State-Sponsored Health Program
United States Diabetes Market
8
United States Diabetes Market
All the 11 Companies Studied in the Report have
been Studied from 3 Points   Company
Overview   Recent Developments   Financial
Insight Company Analysis 1.    B. Braun
Melsungen AG 2.    Eli Lilly and Company3.  
 Artsana S.p.A 4.    BD5.    Novo Nordisk
A/S 6.    Owen Mumford Ltd7.    Ypsomed
AG 8.    Medtronic9.    Insulet
Corporation 10.    LifeScan Inc.11.    Abbott
Laboratories
United States Diabetes Market
9
United States Diabetes Market
Browse Related Report CAR T Cell Therapy
Market Hepatitis C Drugs Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com
United States Diabetes Market